Stay updated on Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.

Latest updates to the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check23 days agoChange DetectedA notice says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.8%

- Check30 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe footer now displays software revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history now shows a new revision v3.7.0, replacing the previous v3.6.6, indicating that the study record has been updated.SummaryDifference0.1%

- Check80 days agoChange DetectedThe record history now shows a new revision entry labeled v3.6.6, replacing the earlier v3.6.5. This reflects an update to the study record's version history rather than substantive study data.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.